Issued on 7 April:"AOD9604 Clinical Trial Recruitment UpdateWe...

Issued on 7 April:

"AOD9604 Clinical Trial Recruitment Update
We are pleased to advise that as of last Friday, 225 patients have now been enrolled in the Company’s 300-patient Phase 2b clinical trial on obesity drug AOD9604, reflecting a substantial increase in the recruitment rate.

A further update will be provided on completion of enrolment".

I think that it may take say another month to get all the patients enrolled. An Announcement to that effect will be nice.

The trial itself will be for three months (Last patient to be served three months after enrollment on say 7 May).

They originally suggested that the trial would finish 2Q with report in 3Q.

However, due to delay with enrollment, say the trial now completes on 7 Aug and the Report could be some 2/3 months later, say Oct/Nov.

BigChart:
http://bigcharts.marketwatch.com/javachart/javachart.asp?symb=au%3AEPT&time=&freq=

I made a small investment @95 cents yesterday

Gerry
Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.

I need to update the existing study thread.